Literature DB >> 12489582

Imaging of neuroendocrine tumors of the pancreas.

J L Fidler1, C D Johnson.   

Abstract

BACKGROUND: Neuroendocrine tumors of the pancreas are uncommon neoplasms of the pancreas that can occur sporadically or in association with various syndromes such as multiple endocrine neoplasia type 1 (MEN I). Patients can present with a specific clinical syndrome related to biochemically functioning tumors or with nonspecific symptoms related to mass effect or metastases. The size, function, consistency, and malignant behavior of neuroendocrine tumors are integrally related. Imaging has a major role in the preoperative localization of the primary tumor and detection of metastases. Several techniques are available including ultrasound, endoscopic ultrasound, computed tomography (CT), MR, somatostatin receptor scintigraphy, angiography, and arterial stimulation with venous sampling; each with unique advantages and limitations. The reported performance for these techniques vary widely, and as a result, recommended imaging algorithms are controversial. Recent technical advances in ultrasound, CT, and MRI have occurred that may improve the sensitivity of some of the techniques. Further improvements are likely in the future. In this chapter we will review imaging techniques used to study the pancreas as it relates to the detection of neuroendocrine tumors, imaging findings of these tumors using various imaging modalities, and the advantages, limitations and results obtained with each technique.

Entities:  

Mesh:

Year:  2001        PMID: 12489582     DOI: 10.1385/ijgc:30:1-2:073

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  76 in total

1.  Localization of insulinomas. Comparison of conventional arterial stimulation with venous sampling (ASVS) and superselective ASVS.

Authors:  Y Baba; N Miyazono; M Nakajo; I Kanetsuki; H Nishi; H Inoue
Journal:  Acta Radiol       Date:  2000-03       Impact factor: 1.990

2.  Delayed enhancement of islet cell carcinoma on dynamic computed tomography: a sign of its malignancy.

Authors:  K Koito; T Namieno; T Nagakawa; K Morita
Journal:  Abdom Imaging       Date:  1997 May-Jun

3.  Insulinoma: diagnosis with fat-suppressed MR imaging.

Authors:  B B Kraus; P R Ros
Journal:  AJR Am J Roentgenol       Date:  1994-01       Impact factor: 3.959

4.  Localization of insulinomas.

Authors:  M P Boukhman; J M Karam; J Shaver; A E Siperstein; A A DeLorimier; O H Clark
Journal:  Arch Surg       Date:  1999-08

5.  Endoscopic ultrasonography for the preoperative localization of insulinomas.

Authors:  J Pitre; O Soubrane; L Palazzo; Y Chapuis
Journal:  Pancreas       Date:  1996-07       Impact factor: 3.327

6.  SPECT imaging with 111In-octreotide for the localization of pancreatic insulinoma.

Authors:  A Signore; E Procaccini; M Chianelli; G Salerno; P Iozzo; A Annovazzi; F Leonetti; G Tamburrano; G Ronga
Journal:  Q J Nucl Med       Date:  1995-12

7.  Prospective study of provocative angiograms to localize functional islet cell tumors of the pancreas.

Authors:  M S Cohen; D Picus; T C Lairmore; S M Strasberg; G M Doherty; J A Norton
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

8.  Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe.

Authors:  A Benevento; L Dominioni; G Carcano; R Dionigi
Journal:  Semin Surg Oncol       Date:  1998-12

9.  Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.

Authors:  R C Semelka; M J Cumming; J P Shoenut; C M Magro; C S Yaffe; M A Kroeker; H M Greenberg
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

10.  Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy.

Authors:  R J Weinel; C Neuhaus; J Stapp; H J Klotter; M E Trautmann; K Joseph; R Arnold; M Rothmund
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

View more
  6 in total

1.  Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours.

Authors:  Carla Cappelli; Ugo Boggi; Salvatore Mazzeo; Rosa Cervelli; Daniela Campani; Niccola Funel; Benedetta Pontillo Contillo; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2014-12-02       Impact factor: 5.315

2.  Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case.

Authors:  Naoki Yazawa; Toshihide Imaizumi; Ken-ichi Okada; Masahiro Matsuyama; Shoichi Dowaki; Kosuke Tobita; Yasuo Ohtani; Kyoji Ogoshi; Kenichi Hirabayashi; Hiroyasu Makuuchi
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 3.  Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Authors:  Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

4.  The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report.

Authors:  G Tamagno; E De Carlo; C Martini; D Rubello; F Fallo; N Sicolo
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

5.  CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.

Authors:  Nassim Fard; Heinz-Peter Schlemmer; Friedhelm Raue; Björn Jobke
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

6.  GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT.

Authors:  A O Oladejo
Journal:  Ann Ib Postgrad Med       Date:  2009-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.